Latest News

Baron & Budd Obtains $11,850,000 Settlement in False Claims Act Case Against Sanofi-Aventis U.S., LLC





WASHINGTON–(BUSINESS WIRE)– #becomeawhistleblower–Today, the nationally recognized attorneys from Baron & Budd obtained an $11,850,000 settlement in a case against pharmaceutical marketing company, Sanofi-Aventis U.S., LLC. The company markets drugs, including Lemtrada, a treatment for patients with multiple sclerosis (MS). In this case, a whistleblower came forward with information alleging that Sanofi was paying kickbacks to physicians and patients. The scheme was allegedly perpetrated by making the cost of L

Source link





Related posts

Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)

Newsemia

EWTOPIA75: Ezetimibe prevents CV events in elderly patients

Newsemia

STAT Plus: There are fewer opioid prescriptions being written for Medicare Part D beneficiaries

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy